EyePoint (EYPT) CEO Duker reports RSU vesting and tax-share withholding
Rhea-AI Filing Summary
EyePoint, Inc. President and CEO Jay S. Duker, who also serves as a director, reported routine equity activity on January 6, 2026 related to previously granted restricted stock units. A block of 20,793 restricted stock units converted into the same number of shares of common stock at an exercise price of $0.00, reflecting vesting of his equity award. To cover taxes on this vesting, 10,054 shares of common stock were withheld by EyePoint at a price of $16.86, and the filing specifies that no shares were sold in the market. After these transactions, Duker directly held 77,752 shares of common stock, and an additional 99,165 shares were reported as indirectly held by a family trust for the benefit of his children, for which he disclaims beneficial ownership.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 20,793 | $0.00 | -- |
| Exercise | Common Stock | 20,793 | $0.00 | -- |
| Tax Withholding | Common Stock | 10,054 | $16.86 | $170K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units. These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. The restricted stock units vest in three ratable annual installments beginning January 6, 2024.
FAQ
What insider transaction did EyePoint (EYPT) report for CEO Jay S. Duker?
Jay S. Duker reported the vesting and conversion of 20,793 restricted stock units into the same number of EyePoint common shares on January 6, 2026, at an exercise price of $0.00.
How do the restricted stock units for the EyePoint (EYPT) CEO vest over time?
The filing notes that the restricted stock units vest in three ratable annual installments beginning on January 6, 2024, leading to the January 6, 2026 vesting event.